The Korean Journal of Health Service Management (보건의료산업학회지)

Korea Society of Health Service Management (보건의료산업학회)
권호 표지
DOI QR코드

DOI QR Code

Prescription Characteristics of Medication for Acute Respiratory Diseases before and after Pay-for-Performance -using National Health Insurance Big data-

의원 가감지급사업 실시 전후에 따른 급성호흡기계질환의 의약품 처방특성 -국민건강보험 빅데이터를 활용하여-

  • Gong, Mi-Jin (Graduate School of Catholic University of Pusan) ;
  • Hwang, Byung-Deog (Department of Health Care Management Catholic University of Pusan)
  • 공미진 (부산가톨릭대학교 일반대학원 병원경영학전공) ;
  • 황병덕 (부산가톨릭대학교 병원경영학과)
  • Received : 2020.01.10
  • Accepted : 2020.02.26
  • Published : 2020.03.31
Download PDF
⟨ Previous Next ⟩

Abstract

Objectives: This study analyzed the prescription characteristics of medication for acute respiratory diseases before and after pay-for-performance to provide basic data on effective medical quality management policies. Methods: The research data were collected from the 2013-2014 sample cohort of the National Health Insurance Corporation, from Internal Medicine, Pediatrics, Otorhinolaryngology, Family Medicine and General practitioner clinics (classification of disease codes: J00-J06, J20-J22, J40 outpatients). Results: The antibiotics prescription rates decreased from 43.9% in 2013 to 43.5% in 2014 when the major diagnosis was for upper respiratory infections and increased from 62.0% in 2013 to 62.5% in 2014 when the major diagnosis was for lower respiratory infections. Conclusions: There is a need to identify the correct antibiotic prescription method by expanding the current assessment standards. Such standards must include acute lower respiratory infections and minor diagnoses as the current evaluation techniques focus only on the major diagnosis of acute upper respiratory infections.

Keywords

References

  1. D.T. Jamison, J.G. Breman, A.R. Measham(2006), Disease Control Priorities in Developing Countries. 2nd Edition, Washington(DC): World Bank; 2006, pp.1-27.
  2. KCDC(2014), Analysis of Pathogens in Acute Respiratory Infections, KCDC, pp.1-8
  3. http://kosis.kr/statHtml/statHtml.do?orgId=350&tblId=DT_35001_A0790111&conn_path=I2
  4. KCDC(2013), Disease Centered Pathogen Surveillance Project-Acute Respiratory Infection(ARI Net), KCDC;3(6).
  5. Health Insurance Review & Assessment Service(2018), Evaluation Project on Appropriate Prescribing Indicators Assessment Result Report 2018, HIRA Assessment 4, pp.1.
  6. S.K. Kim, H.E. Kim, M.S. Back, S.H. Lee(2010), The Effect of Public Report on Antibiotics Prescribing Rate, Korea Journal of Clinical Pharmacy, Vol.20(3);242-247.
  7. W. Kim, Y.K. Do, M.W. Jo(2014), A Study on Theoretical Basis and Conceptual Framework for Maximizing the Policy Utilization, HIRA, 2014(57)pp.1-85.
  8. Health Insurance Review & Assessment Service(2015), Evaluation Project on Appropriate Prescribing Indicators Assessment Result Report 2014 Second half, HIRA Assessment 4, pp.1-43.
  9. Organization for Economic Cooperation and Development(2016), OECD Health Statistics 2016. Available from https://www.oecd.org/
  10. H.K. Kang(2012), Efforts to Improve Antibiotic Prescribing Trends for Acute Upper Respiratory Infections in a South Korean University Hospital, Korean J Clin Pham, Vol.22(1):47-54.
  11. D.S. Kim, G. Bae, S.K. Kim, H.S. Lee, Y.J. Kim, S.H. Lee(2012), Retrospective Drug Utilization Review of Antibiotics for Respiratory Tract Infection(RTI) in Ambulatory Outpatient Care, Korean J Clin Pham, Vol.22(4):291-303.
  12. S.M. Chae, E.J. Park, S.V. Park(2013), Antibiotic Consumption and Expenditures for Acute Upper Respiratory Tract Infections in Outpatients, Yakhak Hoeji, Vol.57(3);199-204.
  13. Y.J. Kim, S.H. Lee, S.V. Park, H.O. Na, B.H. Choi(2015), Outpatient Antibiotic Prescription Patterns for Respiratory Tract Infections of Infants, Health Policy and Management, Vol.25(4);323-332. https://doi.org/10.4332/KJHPA.2015.25.4.323
  14. W.J. Choi, E.S. Yim, T.H. Kim, H.S. Suh, K.C. Choi, W.J. Chung(2015), Analysis of Factors Related to the Prescription of Antibiotics for the Acute Upper Respiratory Infection, Health Policy and Management, Vol.25(4);256-263. https://doi.org/10.4332/KJHPA.2015.25.4.256
  15. http://kosis.kr/statHtml/statHtml.do?orgId=350&tblId=DT_35001_0781111&conn_path=I2
  16. KOSIS(2013), Analysis of Main Characteristics and Changes by Life Cycle, KOSIS, pp.4
  17. M.J. Gong, B.D. Hwang(2017), Clinical Department Prescription Drugs Characteristics of Acute Upper Respiratory Tract Infection Disease, The Korean Journal of Health Service Management, Vol.11(3);37-49. https://doi.org/10.12811/kshsm.2017.11.3.037
  18. Health Insurance Review & Assessment Service(2014), Evaluation Project on Appropriate Prescribing Indicators Assessment Result Report 2014 First half, HIRA Assessment 4, pp.3-36.
  19. J.A. Kim, H.Y. Lee, S.J. Kim(2017), Outpatient Drug Adequacy Evaluation Model Improvement Study, HIRA, 2017(136)pp.1-257.
  20. S.H. Jang(2016), Analysis of Factors Affecting the Injections Prescription, Department of Health Policy and Hospital Management Graduate School of Public Health, Korea University, pp.1-134.